Diabetes Mellitus, Type 2: all 9,589 studies
Page 86 of 96. Open to participants first (1,332), then studies with results posted, then the rest; newest registration first within each.
- Metabolic Causes of Thrombosis in Type 2 Diabetes MellitusCompletedNCT00829699Early Phase 1
- Acarbose Cardiovascular Evaluation TrialCompletedNCT00829660Phase 4
- n-3 Fatty Acid Infusion and Type 2 DiabetesCompletedNCT00829569Not applicable
- Observational Study to Evaluate the Safety of Levemir® in Type 2 DiabetesCompletedNCT00825643
- Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM)CompletedNCT00825383Not applicable
- Pharmacokinetics and Pharmacodynamics of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 in Type 2 DiabetesCompletedNCT00825253Phase 1
- Impact of Accu-Chek 360 in Veterans With Type 2 DiabetesCompletedNCT00824694Not applicable
- Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 DiabetesCompletedNCT00824668Phase 1
- Development, Implementation and Evaluation of a Complex Regional Intervention for Type 2 Diabetes: Diabetes Project AalstStatus unknownNCT00824499Not applicable
- Home-Based Walking Study in Older Adults With Type 2 DiabetesCompletedNCT00824330Not applicable
- A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin MonotherapyCompletedNCT00823992Phase 3
- Glycemic Response to Momordica Charantia in Type 2 DiabetesWithdrawnNCT00823953Phase 2
- A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal SubjectsCompletedNCT00823940Phase 1
- Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedNCT00823849Phase 4
- A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of MetforminCompletedNCT00823680Phase 2
- Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 DiabetesCompletedNCT00822367Not applicable
- Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin MonotherapyCompletedNCT00822211Phase 3
- Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesCompletedNCT00821977Phase 2/3
- Blood Glucose Homeostasis in Type 2 Diabetes: the Effects of SaccharoseCompletedNCT00821665Not applicable
- Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 DiabetesCompletedNCT00819975Not applicable
- To Evaluate 24-hr Glucose After OD vs BD AZD1656CompletedNCT00819884Phase 1
- Use of Information Technology in the Prevention of DiabetesCompletedNCT00819455Not applicable
- Prevention of Instent Renarrowing With Aggressive Glucose Lowering With Pioglitazone in Diabetic PatientsCompletedNCT00819325Phase 4
- Low-Intermediate-Glycemic Index Caribbean Foods Versus High Glycemic Index Foods in Type 2 DiabetesCompletedNCT00818935Not applicable
- Differential Effects of Protein Quality on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes: Comparison of Whey, Casein, Gluten, and Cod ProteinCompletedNCT00817973Not applicable
- Molecular Mechanisms of Type 2 Diabetes MellitusCompletedNCT00816218Phase 4
- Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and DiabetesTerminatedNCT00816010Not applicable
- Pioglitazone Versus Metformin in Type 2 DiabetesCompletedNCT00815399Phase 4
- Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle WeaknessCompletedNCT00815178Not applicable
- Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminTerminatedNCT00814372Phase 2
- Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes MellitusCompletedNCT00814294Phase 2/3
- Effect of Internet Therapeutic Intervention on A1C Levels in Type 2 Diabetes Mellitus (DM)CompletedNCT00814190Not applicable
- Lifestyle Intervention For Effective Diabetes ManagementStatus unknownNCT00813930Not applicable
- Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy IndividualsCompletedNCT00813228Phase 1
- Postprandial DysmetabolismStatus unknownNCT00813215Not applicable
- A Clinical Trial Investigating the Comparison of Three Different Concentrations of NN9535 in Healthy Male SubjectsCompletedNCT00813020Phase 1
- Metabolic Effects of Vitamin D in Patients With Type 2 DiabetesCompletedNCT00812578Phase 2
- Diabetes Connect: Patients and Providers Use of a Secure Website for Blood Glucose Monitoring in Type-2 DiabetesCompletedNCT00812539Not applicable
- Evaluation of Antiplatelet Effects of Different Dosages of Aspirin in Type 2 Diabetic PatientsCompletedNCT00812032Phase 4
- Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT00811889Phase 2
- A Study of Taspoglutide in Type 2 Diabetic PatientsCompletedNCT00811460Phase 1
- The Effect of Gastric Bypass Surgery on the Glucose Metabolism Seen in Patients With Type 2 DiabetesCompletedNCT00810823
- Phone Call in Type 2 Diabetes PatientCompletedNCT00810173Not applicable
- A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 DiabetesCompletedNCT00809705Phase 3
- Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic PatientsCompletedNCT00808860Phase 1/2
- Orthostatic Hypotension and Diabetes MellitusCompletedNCT00807976
- Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic PatientsStatus unknownNCT00806975Not applicable
- Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes SubjectsCompletedNCT00806936
- Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®CompletedNCT00806897
- Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes MellitusCompletedNCT00806858
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic ControlCompletedNCT00806520
- A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in ThailandCompletedNCT00805922
- Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly ExenatideCompletedNCT00803920
- Survey on the Treatment of Hypertension in Patients With Type 2 DiabetesCompletedNCT00803660
- Incretin Effect in Lean and Obese SubjectsCompletedNCT00803296
- Exploratory Study of Iocide Oral Rinse in a Diabetic PopulationCompletedNCT00801164Phase 1
- Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 DiabetesTerminatedNCT00799448Phase 4
- Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes MellitusCompletedNCT00798915Phase 1
- Comparison of Nutritional Products for People With Type 2 DiabetesCompletedNCT00797069Phase 3
- Diabetes Dietary Study- Low Carbohydrate and Low-Fat Diets in Type 2 DiabetesCompletedNCT00795691Not applicable
- Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.CompletedNCT00793273
- Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADsCompletedNCT00791895Phase 4
- A Study to Assess the Safety and Tolerability of ASP1941 in Adults With Type 2 Diabetes Mellitus.CompletedNCT00790660Phase 2
- Reducing Weight and Diabetes Risk in an Underserved Population (STRIDE)CompletedNCT00790517Not applicable
- To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 SuspensionCompletedNCT00790153Phase 1
- An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of DiabetesCompletedNCT00789711
- Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 DiabetesTerminatedNCT00789282Not applicable
- A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Diabetic Subjects in IndonesiaCompletedNCT00788853
- Detemir Energy Expenditure StudyCompletedNCT00788840Phase 4
- Impact of GBS on CVD in Type 2 Diabetes MellitusCompletedNCT00787670Not applicable
- Mitochondria and Metabolic Syndrome in a Southern California Chinese CohortCompletedNCT00786721
- Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic PatientsCompletedNCT00786500Phase 1/2
- What Makes Exercise Feel More Difficult to Women With and Without Type 2 DiabetesCompletedNCT00785005
- Insulin Glargine Combination Therapies in Type II DiabeticsCompletedNCT00783744Phase 3
- Predictive Genetic Risk Assessment TrialCompletedNCT00782366
- Determinants of Insulin-induced Weight Gain in Type 2 Diabetes MellitusStatus unknownNCT00781495
- Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix InsulinCompletedNCT00775736
- Hyperglycemia and Oxidative Stress in the Human Brain With DiabetesTerminatedNCT00775541Not applicable
- Project Diabetes: Prescription for Healthy LivingTerminatedNCT00775216Not applicable
- To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of MetforminCompletedNCT00774553Phase 1
- Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)CompletedNCT00771693Phase 4
- Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 DiabetesCompletedNCT00771680
- Hypertensive Treatment Pattern Survey for Type II Diabetes Mellitus Patients With Complication and HypertensionCompletedNCT00771069
- Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.CompletedNCT00770952Phase 3
- Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.CompletedNCT00770640Phase 2
- Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)CompletedNCT00770081Phase 3
- Detection of Ischemia in Asymptomatic DiabeticsCompletedNCT00769275
- To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of InsulinCompletedNCT00768105Phase 1
- Variation in Serum Levels of Metformin in Patients With Reduced Renal FunctionCompletedNCT00767351
- Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes MellitusCompletedNCT00767260Phase 1/2
- Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart FailureCompletedNCT00766857Phase 4
- Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight LossCompletedNCT00766298Not applicable
- Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)CompletedNCT00765830Phase 3
- Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2CompletedNCT00763802
- Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusCompletedNCT00763022Phase 3
- Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TerminatedNCT00762957Phase 3
- Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762684Phase 3
- Signaling Mechanisms and Vascular Function in Patients With Diabetes MellitusCompletedNCT00762671Phase 2/3
- Metabolomic Profiling of Novel Mediators of Vascular FunctionTerminatedNCT00762242
- Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTerminatedNCT00762190Phase 3